Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12517419rdf:typepubmed:Citationlld:pubmed
pubmed-article:12517419lifeskim:mentionsumls-concept:C0025914lld:lifeskim
pubmed-article:12517419lifeskim:mentionsumls-concept:C0026809lld:lifeskim
pubmed-article:12517419lifeskim:mentionsumls-concept:C0003069lld:lifeskim
pubmed-article:12517419lifeskim:mentionsumls-concept:C0312738lld:lifeskim
pubmed-article:12517419lifeskim:mentionsumls-concept:C0376515lld:lifeskim
pubmed-article:12517419lifeskim:mentionsumls-concept:C0596988lld:lifeskim
pubmed-article:12517419lifeskim:mentionsumls-concept:C0206414lld:lifeskim
pubmed-article:12517419lifeskim:mentionsumls-concept:C0392756lld:lifeskim
pubmed-article:12517419lifeskim:mentionsumls-concept:C1521828lld:lifeskim
pubmed-article:12517419pubmed:issue1-2lld:pubmed
pubmed-article:12517419pubmed:dateCreated2003-1-8lld:pubmed
pubmed-article:12517419pubmed:abstractTextTo assess mutagenesis during early B-lymphocyte development in vitro, progenitor B cells (pre-B cells) were obtained from fetal livers of BALB/c mice and DBA/2N mice that harbored the transgenic shuttle vector, pUR288, with a lacZ reporter gene for the determination of mutant frequencies (MFs). Differentiation-arrested pre-B cells demonstrated a marked dose-dependent increase in lacZ mutant levels after exposure to gamma-irradiation with a peak MF of 250 x 10(-5) at 2.5 Gy. Without genotoxic treatment, pre-B cells undergoing spontaneous differentiation into surface IgM expressing immature B cells exhibited lacZ mutant levels of up to 95 x 10(-5). The mutational pattern was dominated in both experiments by illegitimate recombination mutations of lacZ, not point mutations. Likewise, in both experiments, the enforced expression of Bcl-2 resulted in a striking reduction of lacZ mutations. These findings indicated that mouse pre-B cells are prone to accumulate induced and self-inflicted mutations, particularly recombinations. Additionally, our studies revealed a heretofore unknown role of Bcl-2 in inhibiting mutagenesis during early B-cell development in mice.lld:pubmed
pubmed-article:12517419pubmed:languageenglld:pubmed
pubmed-article:12517419pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12517419pubmed:citationSubsetIMlld:pubmed
pubmed-article:12517419pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12517419pubmed:statusMEDLINElld:pubmed
pubmed-article:12517419pubmed:monthJanlld:pubmed
pubmed-article:12517419pubmed:issn0027-5107lld:pubmed
pubmed-article:12517419pubmed:authorpubmed-author:RolinkAntoniu...lld:pubmed
pubmed-article:12517419pubmed:authorpubmed-author:MelchersFritz...lld:pubmed
pubmed-article:12517419pubmed:authorpubmed-author:JanzSiegfried...lld:pubmed
pubmed-article:12517419pubmed:authorpubmed-author:FelixKlausKlld:pubmed
pubmed-article:12517419pubmed:copyrightInfoCopyright 2002 Elsevier Science B.V.lld:pubmed
pubmed-article:12517419pubmed:issnTypePrintlld:pubmed
pubmed-article:12517419pubmed:day28lld:pubmed
pubmed-article:12517419pubmed:volume522lld:pubmed
pubmed-article:12517419pubmed:ownerNLMlld:pubmed
pubmed-article:12517419pubmed:authorsCompleteYlld:pubmed
pubmed-article:12517419pubmed:pagination135-44lld:pubmed
pubmed-article:12517419pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:12517419pubmed:meshHeadingpubmed-meshheading:12517419...lld:pubmed
pubmed-article:12517419pubmed:meshHeadingpubmed-meshheading:12517419...lld:pubmed
pubmed-article:12517419pubmed:meshHeadingpubmed-meshheading:12517419...lld:pubmed
pubmed-article:12517419pubmed:meshHeadingpubmed-meshheading:12517419...lld:pubmed
pubmed-article:12517419pubmed:meshHeadingpubmed-meshheading:12517419...lld:pubmed
pubmed-article:12517419pubmed:meshHeadingpubmed-meshheading:12517419...lld:pubmed
pubmed-article:12517419pubmed:meshHeadingpubmed-meshheading:12517419...lld:pubmed
pubmed-article:12517419pubmed:meshHeadingpubmed-meshheading:12517419...lld:pubmed
pubmed-article:12517419pubmed:meshHeadingpubmed-meshheading:12517419...lld:pubmed
pubmed-article:12517419pubmed:meshHeadingpubmed-meshheading:12517419...lld:pubmed
pubmed-article:12517419pubmed:meshHeadingpubmed-meshheading:12517419...lld:pubmed
pubmed-article:12517419pubmed:meshHeadingpubmed-meshheading:12517419...lld:pubmed
pubmed-article:12517419pubmed:meshHeadingpubmed-meshheading:12517419...lld:pubmed
pubmed-article:12517419pubmed:meshHeadingpubmed-meshheading:12517419...lld:pubmed
pubmed-article:12517419pubmed:meshHeadingpubmed-meshheading:12517419...lld:pubmed
pubmed-article:12517419pubmed:meshHeadingpubmed-meshheading:12517419...lld:pubmed
pubmed-article:12517419pubmed:meshHeadingpubmed-meshheading:12517419...lld:pubmed
pubmed-article:12517419pubmed:year2003lld:pubmed
pubmed-article:12517419pubmed:articleTitleBcl-2 reduces mutant rates in a transgenic lacZ reporter gene in mouse pre-B lymphocytes.lld:pubmed
pubmed-article:12517419pubmed:affiliationLaboratory of Genetics, Center for Cancer Research, National Cancer Institute, Room 2B10, Building 37, NIH, Bethesda, MD 20892-4255, USA.lld:pubmed
pubmed-article:12517419pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12517419pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed